Blue Water Vaccines Statistics
Share Statistics
Blue Water Vaccines has 18.9M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 18.9M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,827 |
| FTD / Avg. Volume | 0.65% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.02 and the forward
PE ratio is null.
Blue Water Vaccines's PEG ratio is
0.
| PE Ratio | -1.02 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.6 |
| P/FCF Ratio | -1.55 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Blue Water Vaccines has an Enterprise Value (EV) of -12.25M.
| EV / Sales | 0 |
| EV / EBITDA | 0.91 |
| EV / EBIT | 1.41 |
| EV / FCF | 1.41 |
Financial Position
The company has a current ratio of 6.69,
with a Debt / Equity ratio of 0.
| Current Ratio | 6.69 |
| Quick Ratio | 6.69 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 219.53 |
Financial Efficiency
Return on Equity is -59.36% and Return on Invested Capital is -59.63%.
| Return on Equity | -59.36% |
| Return on Assets | -50.51% |
| Return on Invested Capital | -59.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,107,521.5 |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -129.57K |
| Effective Tax Rate | 0.97% |
Stock Price Statistics
The stock price has increased by 3.75% in the
last 52 weeks. The beta is 0, so Blue Water Vaccines's
price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | 3.75% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.72 |
| Relative Strength Index (RSI) | 32.4 |
| Average Volume (20 Days) | 435,531 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.48M |
| Net Income | -13.29M |
| EBITDA | -13.48M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.08 |
Full Income StatementBalance Sheet
The company has 25.75M in cash and 0 in
debt, giving a net cash position of 25.75M.
| Cash & Cash Equivalents | 25.75M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -19.38M |
| Total Assets | 27.88M |
| Working Capital | -8.1M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.7M
and capital expenditures -9.34K, giving a free cash flow of -8.71M.
| Operating Cash Flow | -8.7M |
| Capital Expenditures | -9.34K |
| Free Cash Flow | -8.71M |
| FCF Per Share | -0.71 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
